Cargando…

Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China

BACKGROUND AND PURPOSE: Data on the efficacy and safety of alteplase for acute ischaemic stroke (AIS) administered 3–4.5 hours after the onset of stroke symptoms in Chinese patients is limited. We sought to determine whether AIS patients would benefit from thrombolysis with alteplase between 3 and 4...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Huaguang, Yang, Yi, Chen, Huisheng, Li, Chuanling, Chen, Yangkun, Shi, Fu-Dong, Yang, Li, Cui, Xiaoping, Lu, Zuneng, Liang, Yanling, Cui, Songbiao, Xu, Anding, Wu, Yiqing, Sun, Yaqing, Wang, Yongjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548519/ https://www.ncbi.nlm.nih.gov/pubmed/32467323 http://dx.doi.org/10.1136/svn-2020-000337

Ejemplares similares

Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances
por: Alper, Brian Scott, et al.
Publicado: (2020)

The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke
por: Dong, Qiang, et al.
Publicado: (2017)

Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study
por: Dhar, Nikita, et al.
Publicado: (2022)

Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study
por: Li, Shuya, et al.
Publicado: (2021)

Bolus-Infusion Delays of Alteplase during Thrombolysis in Acute Ischaemic Stroke and Functional Outcome at 3 Months
por: Acheampong, Paul, et al.
Publicado: (2014)

Economic evaluation of intravenous alteplase for stroke with the time of onset between 4.5 and 9 hours
por: Chen, Jigang, et al.
Publicado: (2023)

Safety of intravenous alteplase within 4.5 hours for patients awakening with stroke symptoms
por: Urrutia, Victor C., et al.
Publicado: (2018)

Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
por: Yang, Nan, et al.
Publicado: (2023)

Cost-Effectiveness of Thrombolysis within 4.5 Hours of Acute Ischemic Stroke in China
por: Pan, Yuesong, et al.
Publicado: (2014)

Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit—TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit
por: Bivard, Andrew, et al.
Publicado: (2022)

Uric acid enhances alteplase-mediated thrombolysis as an antioxidant
por: Kikuchi, Kiyoshi, et al.
Publicado: (2018)

Intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction
por: Gao, Lilin, et al.
Publicado: (2022)

Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis
por: Fanikos, John, et al.
Publicado: (2021)

Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022)

Silver Jubilee of Stroke Thrombolysis With Alteplase: Evolution of the Therapeutic Window
por: Pan, Yuanmei, et al.
Publicado: (2021)

Effect of Apixaban Pretreatment on Alteplase-Induced Thrombolysis: An In Vitro Study
por: Thalerová, Sandra, et al.
Publicado: (2021)

Effect of Alteplase Thrombolysis on Coagulation Function and Nerve Function of Patients with Ischemic Stroke
por: Zhao, Hong-Ying, et al.
Publicado: (2022)

Risk Factors for Early Intracerebral Hemorrhage after Intravenous Thrombolysis with Alteplase
por: Lin, Xianda, et al.
Publicado: (2020)

Early changes in fibrinogen after administration of alteplase are associated with the short-term efficacy of thrombolysis
por: Lu, Tao, et al.
Publicado: (2018)

Determinants of 1-Year Unfavorable Outcomes of Intravenous Alteplase Thrombolysis for Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023)

Edaravone, a Synthetic Free Radical Scavenger, Enhances Alteplase-Mediated Thrombolysis
por: Kikuchi, Kiyoshi, et al.
Publicado: (2017)

Using alteplase nephrostomy tube installation for thrombolysis of ureter tract clot obstruction
por: Lin, Paoyan, et al.
Publicado: (2021)

Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns
por: Dong, Yi, et al.
Publicado: (2021)

Normal Appearing Ischaemic Brain Tissue on CT and Outcome After Intravenous Alteplase
por: Mair, Grant, et al.
Publicado: (2022)

Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis
por: Tan, Ge, et al.
Publicado: (2017)

Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion
por: Nie, Ximing, et al.
Publicado: (2021)

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
por: Emberson, Jonathan, et al.
Publicado: (2014)

Hyperdense artery sign, symptomatic infarct swelling and effect of alteplase in acute ischaemic stroke
por: Wu, Simiao, et al.
Publicado: (2020)

Treating ischaemic stroke with intravenous tPA beyond 4.5 hours under the guidance of a MRI DWI/T2WI mismatch was safe and effective
por: Bai, Qing-ke, et al.
Publicado: (2019)

A Comparative Study of Hemorrhagic Conversion Patterns After Stroke Thrombolysis With Alteplase Versus Tenecteplase
por: Ezzeldin, Mohamad, et al.
Publicado: (2023)

Successful thrombolysis for acute ischaemic stroke in haemodialysis
por: Power, Albert, et al.
Publicado: (2010)

Safety and Clinical Outcome of Thrombolysis in Ischaemic Stroke Using a Perfusion CT Mismatch between 3 and 6 Hours
por: Sztriha, Laszlo K., et al.
Publicado: (2011)

Alteplase for Acute Ischemic Stroke Beyond 3 hours: Enthusiasm Outpaces Evidence
por: Garg, Ravi
Publicado: (2021)

Different doses of tenecteplase vs. alteplase for acute ischemic stroke within 4.5 hours of symptom onset: a network meta-analysis of randomized controlled trials
por: Liang, Huo, et al.
Publicado: (2023)

Predictors of Postthrombolysis Outcome and Symptomatic Postthrombolysis Hemorrhage following Intravenous Thrombolysis with Alteplase for Acute Ischemic Stroke
por: Das, Suman, et al.
Publicado: (2020)

Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials
por: Xu, Na, et al.
Publicado: (2018)

Subcutaneous haematomas following thrombolysis treatment for ischaemic stroke
por: Thirugnanachandran, Tharani, et al.
Publicado: (2012)

Reasons and evolution of non-thrombolysis in acute ischaemic stroke
por: Reiff, T, et al.
Publicado: (2017)

Early neurological deterioration in acute ischemic stroke patients after intravenous thrombolysis with alteplase predicts poor 3-month functional prognosis - data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Che, Fengli, et al.
Publicado: (2022)

Alteplase for acute ischemic stroke: 2 years in a community hospital without previous experience in stroke thrombolysis
por: Estella, A, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_tce7ghf1bgpis0ulnsgbda9lbu